Literature DB >> 16631303

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.

Jochen Walz1, Markus Graefen, Felix K-H Chun, Andreas Erbersdobler, Alexander Haese, Thomas Steuber, Thorsten Schlomm, Hartwig Huland, Pierre I Karakiewicz.   

Abstract

OBJECTIVES: We explored the yield of saturation biopsy and developed a nomogram predicting the probability of prostate cancer (PCa) on the basis of saturation biopsy.
MATERIALS AND METHODS: Between 2001 and 2004, saturation biopsies (average of 24 cores) were performed in 161 men with persistently elevated prostate specific antigen (PSA) level (median, 9 ng/ml). All had at least two previously negative, eight-core biopsy sessions. PCa predictors on saturation biopsy were integrated within multivariate nomograms.
RESULTS: PCa detection was 41% (n=66 of 161). PSA density and transition zone volume were the most significant predictors of PCa on saturation biopsy. The accuracy of the nomogram with the best performance characteristics was 72%.
CONCLUSIONS: Saturation biopsy may be indicated in men with a persistent suspicion of PCa. High-risk individuals can be identified accurately with our nomogram.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631303     DOI: 10.1016/j.eururo.2006.03.026

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  44 in total

1.  Focal therapy: a new paradigm for the treatment of prostate cancer.

Authors:  Basir Tareen; Guilherme Godoy; Samir S Taneja
Journal:  Rev Urol       Date:  2009

2.  Validation of revised Epstein's criteria for insignificant prostate cancer prediction in a Greek subpopulation.

Authors:  Κ Chondros; Ν Karpathakis; Ι Heretis; Ε Mavromanolakis; N Chondros; F Sofras; C Mamoulakis
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 3.  [Prostate biopsy: Procedure in the clinical routine].

Authors:  T Enzmann; T Tokas; K Korte; M Ritter; P Hammerer; L Franzaring; H Heynemann; H-W Gottfried; H Bertermann; M Meyer-Schwickerath; B Wirth; A Pelzer; T Loch
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

Review 4.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

Review 5.  Role of nomograms for prostate cancer in 2007.

Authors:  Felix K-H Chun; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen
Journal:  World J Urol       Date:  2007-02-27       Impact factor: 4.226

6.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

7.  Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.

Authors:  Shady Nafie; Raj P Pal; John P Dormer; Masood A Khan
Journal:  World J Urol       Date:  2013-12-14       Impact factor: 4.226

Review 8.  Critical review of prostate cancer predictive tools.

Authors:  Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

9.  Image-based clinical decision support for transrectal ultrasound in the diagnosis of prostate cancer: comparison of multiple logistic regression, artificial neural network, and support vector machine.

Authors:  Hak Jong Lee; Sung Il Hwang; Seok-Min Han; Seong Ho Park; Seung Hyup Kim; Jeong Yeon Cho; Chang Gyu Seong; Gheeyoung Choe
Journal:  Eur Radiol       Date:  2009-12-17       Impact factor: 5.315

10.  [Histopathology reports of findings of prostate needle biopsies. Individual treatment].

Authors:  I Damjanoski; J Müller; T J Schnöller; R Küfer; L Rinnab
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.